Pipeline and products
At MucosaTec GmbH, we are working at full speed on new and innovative drugs against influenza. We are also further evolving our platform technology to ensure it can be applied to other viruses in the future.
Development pipline
Drug candidates currently in development based on our adaptable platform technology:
MT-AntiFlu
The first anti-influenza candidate. Antiviral activity was demonstrated in vitro and manufacturing scale already exceeds laboratory scale. Currently in Preclinical development.
MT-AntiHSV-001
The first anti-Herpes Simples Virus candidate currently in discovery stage.
MT-AntiPA-001
The first anti-Pseudomonas Aeruginosa candidate currently in discovery stage.
MT-UroTec-001
The first candidate combating cystitis currently in discovery stage.
MT-ABoost-001
First strategy focussing on enhancing the effectiveness and extending the duration of action of inhaled antibodies in combating lung diseases. Currently in discovery stage.
